Loreal, FR0000120321

L'Oreal stock: Innovist deal adds detail to broad Q3 growth

Published on 11/12/2026 at 17:26 | Editorial responsibility: Rafael MĂŒller, Editor-in-Chief AD HOC NEWS
L'Oreal stock gets fresh strategic context as the group closes its Innovist deal. Nine-month sales reached EUR 35.33 billion as all divisions grew.

Broad growth gains strategic support

  • L'OrĂ©al reported nine-month sales of EUR 35.33 billion, with like-for-like growth of 6.9 percent.
  • All four divisions and all five regions grew, led by Professional Products, Dermatological Beauty and SAPMENA-SSA.
  • The Innovist acquisition and new innovation partnerships expand L'OrĂ©al's strategic footprint in India and cosmetics technology.
Loreal, FR0000120321, Illustration mit AI erstellt.

L'Oréal's third-quarter update added strategic depth to a broad growth profile after the group said it had closed the acquisition of a majority stake in Innovist, an Indian digital-first personal care company. The information appears in L'Oréal's October 22 sales release.

L'Oréal generated EUR 35.33 billion in sales in the first nine months through September 30, up 7.7 percent on a reported basis and 6.9 percent like for like. Third-quarter sales rose to EUR 11.56 billion, with adjusted like-for-like growth accelerating to 7.7 percent.

Growth spreads beyond luxury

All four divisions and all five regions expanded in the nine-month period. Professional Products led the divisions with adjusted like-for-like growth of 12.3 percent, followed by Dermatological Beauty at 11.6 percent. L'Oréal Luxe grew 5.8 percent, while Consumer Products advanced 4.2 percent.

SAPMENA-SSA was the fastest-growing region at 15.8 percent on an adjusted like-for-like basis. Europe grew 7.0 percent and North America 6.3 percent, while Latin America posted 2.4 percent growth despite weakness in Mexico. Fragrances and haircare remained key drivers, with skincare also accelerating.

Strategic moves broaden the outlook

Alongside the Innovist transaction, L'Oréal said its BOLD venture fund and Nykaa had agreed to take minority stakes in high-growth Indian beauty, personal care and wellness brands. The group also signed a memorandum of understanding with Cosmax on next-generation beauty innovation.

L'Oréal stock traded at 445.70 euros on Lang & Schwarz at 17:13 CET on Thursday, November 12, 2026, 0.28 percent below the Xetra close of 446.95 euros on Wednesday, November 11. The quote was below the previous report's 447.00 euros at 12:29 CET, a separate comparison from the Xetra session move.

L'Oréal company and market data

  • Company: L'OrĂ©al S.A.
  • ISIN: FR0000120321
  • Xetra ticker: LOR.DE
  • Lang & Schwarz quote: 445.70 euros, November 12, 2026, 17:13 CET
  • Daily comparison: 0.28 percent below the Xetra close of 446.95 euros on November 11, 2026
  • 52-week range: 340.00 to 454.20 euros
  • Market capitalization: EUR 238.18 billion, November 12, 2026

European investors will continue to watch the CAC 40 as the main French market benchmark.

More news and analyses on L'Oreal stock

Disclaimer...
en | FR0000120321 | LOREAL | boerse | 70499842 | bgmi